| Identifier |
20240303_nanos_posters_088 |
| Title |
Blind Spot in the Battle Against Giant Cell Arteritis |
| Creator |
Amalie Chen; Madhura Shah; Joseph Rizzo III |
| Affiliation |
(AC) Brigham & Women's Hospital, Harvard Medical School, Boston; (MS) Mass Eye and Ear; (JR) Massachusetts Eye and Ear, Harvard Medical School, Boston, MA |
| Subject |
Optic Neuropathy |
| Description |
The accepted treatment for acute giant cell arteritis (GCA) is oral or sometimes IV glucocorticoids. Tocilizumab is the standard of care for long-term management. Almost "immediate" pain relief is a characteristic response to corticosteroid treatment, and absence of response is often attributed to insufficient dosing or an alternative diagnosis. Our case supports medical lore that some patients are relatively resistant to non-methylated corticosteroids. |
| Date |
2024-03 |
| References |
Smutny T, Barvik I, Veleta T, Pavek P, Soukup T. Genetic Predispositions of Glucocorticoid Resistance and Therapeutic Outcomes in Polymyalgia Rheumatica and Giant Cell Arteritis. J Clin Med. 2019;8(5):582. Published 2019 Apr 27. doi:10.3390/jcm8050582 |
| Language |
eng |
| Format |
application/pdf |
| Type |
Text |
| Source |
2024 North American Neuro-Ophthalmology Society Annual Meeting |
| Relation is Part of |
NANOS Annual Meeting 2024: Poster Session: Descriptive Studies I: Neuro-Ophthalmic Disorders of Neurologic and Systemic Diseases |
| Collection |
Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/ |
| Publisher |
North American Neuro-Ophthalmology Society |
| Holding Institution |
Spencer S. Eccles Health Sciences Library, University of Utah |
| Rights Management |
Copyright 2024. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
| ARK |
ark:/87278/s6zyewck |
| Setname |
ehsl_novel_nam |
| ID |
2593930 |
| Reference URL |
https://collections.lib.utah.edu/ark:/87278/s6zyewck |
